Evidence map›Paper›PMID 38902411›Full record

ArticleSurgical endoscopy2024

Evolution of minimally invasive liver surgery in France over the last decade.

Julie Deyrat, David Fuks, Juliette Murris, Emilie Lanoy, Alexandra Nassar, Alix Dhote, Ugo Marchese, Vincent Mallet, Sandrine Katsahian, Martin Gaillard and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Surgical endoscopy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Julie DeyratAP-HP Centre, Groupe Hospitalier Cochin Port-Royal, DMU Cancérologie et Spécialités Médico-Chirurgicales, Service de Chirurgie Hépatobiliaire, Digestive et Endocrinienne, Paris, France.ORCID 0009-0006-4679-5234
David FuksAP-HP Centre, Groupe Hospitalier Cochin Port-Royal, DMU Cancérologie et Spécialités Médico-Chirurgicales, Service de Chirurgie Hépatobiliaire, Digestive et Endocrinienne, Paris, France.
Juliette MurrisUniversité Paris Cité, 75006, Paris, France.
Emilie LanoyUniversité Paris Cité, 75006, Paris, France.
Alexandra NassarAP-HP Centre, Groupe Hospitalier Cochin Port-Royal, DMU Cancérologie et Spécialités Médico-Chirurgicales, Service de Chirurgie Hépatobiliaire, Digestive et Endocrinienne, Paris, France.
Alix DhoteAP-HP Centre, Groupe Hospitalier Cochin Port-Royal, DMU Cancérologie et Spécialités Médico-Chirurgicales, Service de Chirurgie Hépatobiliaire, Digestive et Endocrinienne, Paris, France.
Ugo MarcheseAP-HP Centre, Groupe Hospitalier Cochin Port-Royal, DMU Cancérologie et Spécialités Médico-Chirurgicales, Service de Chirurgie Hépatobiliaire, Digestive et Endocrinienne, Paris, France.
Vincent MalletAP-HP Centre, Groupe Hospitalier Cochin Port-Royal, DMU Cancérologie et Spécialités Médico-Chirurgicales, Service de Chirurgie Hépatobiliaire, Digestive et Endocrinienne, Paris, France.
Sandrine KatsahianUniversité Paris Cité, 75006, Paris, France.
Martin GaillardAP-HP Centre, Groupe Hospitalier Cochin Port-Royal, DMU Cancérologie et Spécialités Médico-Chirurgicales, Service de Chirurgie Hépatobiliaire, Digestive et Endocrinienne, Paris, France.
Stylianos TzedakisAP-HP Centre, Groupe Hospitalier Cochin Port-Royal, DMU Cancérologie et Spécialités Médico-Chirurgicales, Service de Chirurgie Hépatobiliaire, Digestive et Endocrinienne, Paris, France. stylianos.tzedakis@aphp.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite evidence of benefits on postoperative outcomes, minimally invasive liver surgery (MILS) had a very low diffusion up to 2014, and recent evolution is unknown. Our aim was to analyze the recent diffusion and adoption of MILS and compare the trends in indications, extent of resection, and institutional practice with open liver surgery (OLS).

methodsWe analyzed the French nationwide, exhaustive cohort of all patients undergoing a liver resection in France between January 1, 2013 and December 31, 2022. Average annual percentage changes (AAPC) in the incidence of MILS and OLS were compared using mixed-effects log-linear regression models. Time trends were analyzed in terms of extent of resection, indication, and institutional practice.

resultsMILS represented 25.2% of 74,671 liver resections and year incidence doubled from 16.5% in 2013 to 35.4% in 2022. The highest AAPC were observed among major liver resections [+ 22.2% (19.5; 24.9) per year], primary [+ 10.2% (8.5; 12.0) per year], and secondary malignant tumors [+ 9.9% (8.2; 11.6) per year]. The highest increase in MILS was observed in university hospitals [+ 14.7% (7.7; 22.2) per year] performing 48.8% of MILS and in very high-volume (> 150 procedures/year) hospitals [+ 12.1% (9.0; 15.3) per year] performing 19.7% of MILS. OLS AAPC decreased for all indications and institutions and accelerated over time from - 1.8% (- 3.9; - 0.3) per year in 2013-2018 to - 5.9% (- 7.9; - 3.9) per year in 2018-2022 (p = 0.013).

conclusionsThis is the first reported trend reversal between MILS and OLS. MILS has considerably increased at a national scale, crossing the 20% tipping point of adoption rate as defined by the IDEAL framework.

Indexed as

HepatectomyAgedFemaleFranceHumansLaparoscopyLiver NeoplasmsMaleMiddle AgedMinimally Invasive Surgical ProceduresRetrospective StudiesLaparoscopic hepatectomyLaparoscopic liver resectionLiver resectionLiver surgeryMinimally invasive liver surgeryRobotic liver surgery

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.